NASDAQ
Paradigm Biopharmaceuticals Limited (PBIGF) has a interest coverage ratio of -3231.60x as of Friday, May 29, 2026. This represents a 17.35% decrease compared to its 12-month average of -2753.89x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.